Botanical species · safety record

Primula elatior

The EFSA Compendium of Botanicals holds 9 constituent measurements for Primula elatior. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Primula elatior (L.) Hill

9Constituent measurements

0Safety records

4Cited sources

1Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1 licensed products naming Primula elatior as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Root

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Primulasaponin i	Leaves	Solvent extraction	≤ 3.95 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Primulasaponin i	Roots and other underground parts	Solvent extraction	≥ 3.45 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Primulasaponin i	Leaves	Solvent extraction	≥ 1.09 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Primulasaponin i	Flower	Solvent extraction	≤ 0.45 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Primulasaponin i	Flower	Solvent extraction	≥ 0.39 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Primulasaponin i	Roots and other underground parts	Solvent extraction	≤ 3.94 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Gallic acid	Seed	Solvent extraction	—	Unspecified	No resolvable identifier
Saponins	Roots and other underground parts	—	—	Phytochemical screening	No resolvable identifier
Triterpene saponins	Leaves	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Fouad, Mostafa A., Abdel-Hafeez, Azza S. Chemical and biological studies of the methanolic extract of Primula elatior L. seeds. Bulletin of pharmaceutical sciences, assiut university, 2009, p. 111-123.
Muller, A., Ganzera, M., Stuppner, H. Analysis of phenolic glycosides and saponins in Primula elatior and Primula veris (primula root) by liquid chromatography, evaporative light scattering detection and mass spectrometry. JOURNAL OF CHROMATOGRAPHY A, 2006, vol. 1112, no. 1-2, p. 218-223. DOI
Kofler, L., Brauner, M. The saponin of Primula root. II. Festschrift a. tschirch, 1926, p. 351-356.
Vermeersch, Marieke., Foubert, Kenn., Da Luz, Raquel Inocencio., Van Puyvelde, Luc., Pieters, Luc., Cos, Paul., Maes, Louis. Selective antileishmania activity of 13,28-epoxy-oleanane and related triterpene saponins from the plant families Myrsinaceae, Primulaceae, Aceraceae an Icacinaceae. Phytotherapy research, 2009, p. 1404-1410.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature